GSK Begins Detailing Xenical Ahead Of OTC Switch Opportunity
This article was originally published in The Pink Sheet Daily
Executive Summary
GlaxoSmithKline's Consumer Healthcare division will detail the weight-loss therapy, focusing on diabetes risk reduction data recently added to labeling. Xenical was last detailed by Roche in November 2003. The Rx-to-OTC application is planned for mid-year.